Hasil Pencarian - S. E. Assouline

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study

    Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study oleh Adi J. Klil-Drori, Hui Yin, Laurent Azoulay, Michaël Harnois, Michel-Olivier Gratton, Lambert Busque, Sarit E. Assouline

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway

    Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway oleh Benet Pera, Jan Krumsiek, Sarit E. Assouline, Rossella Marullo, Jayeshkumar Patel, Jude M. Phillip, Lidia Román, Koren K. Mann, Leandro Cerchietti

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Telomerase contributes to fludarabine resistance in primary human leukemic lymphocytes.

    Telomerase contributes to fludarabine resistance in primary human leukemic lymphocytes. oleh May Shawi, Tsz Wai Chu, Veronica Martinez-Marignac, Y Yu, Sergei M Gryaznov, James B Johnston, Susan P Lees-Miller, Sarit E Assouline, Chantal Autexier, Raquel Aloyz

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Systemic Cancer Therapy:

    Systemic Cancer Therapy: oleh Michael Ostario Palumbo, Petr eKavan, Wilson eMiller, Lawrence ePanasci, Sarit eAssouline, Nathalie eJohnson, Victor eCohen, Francois ePatenaude, Michael ePollak, R Thomas Jagoe, Gerald eBatist

    Diterbitkan 2013-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P1152: RESULTS FROM A PHASE I PHARMACOKINETIC (PK) AND SAFETY STUDY OF TRPH-222, A NOVEL CD22-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R NHL)

    P1152: RESULTS FROM A PHASE I PHARMACOKINETIC (PK) AND SAFETY STUDY OF TRPH-222, A NOVEL CD22-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HOD... oleh F. J. Hernandez-Ilizaliturri, J. Kuruvilla, B. A. Christian, I. W. Flinn, S. E. Assouline, M. L. Ulrickson, D. J. Landsburg, M. Stuart, H. Lowman, N. Levin, D. Maetzel, N. N. Viller, A. MacLaren

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Monitoring response and resistance to the novel arsenical darinaparsin in an AML patient

    Monitoring response and resistance to the novel arsenical darinaparsin in an AML patient oleh Torsten Holm eNielsen, Nathalie eJohnson, Nicolas eGarnier, Stanley eKwan, Lu eYao, Eftihia eCocolakis, Josée eHébert, Robert A. Morgan, Éric ePaquet, Kevin P. Callahan, Craig T. Jordan, Sarit eAssouline, Wilson H. Miller, Koren K. Mann

    Diterbitkan 2013-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P500: A REAL WORLD MULTI CENTRE STUDY OF CPX-351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG-IDA AND 3 + 7 IN HIGH RISK AML.

    P500: A REAL WORLD MULTI CENTRE STUDY OF CPX-351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG-IDA AND 3 + 7 IN HIGH RISK AML. oleh C. Andrews, I. AlNabhani, T. Young, E. G. Atenafu, S. E. Assouline, J. M. Brandwein, S. M. Chan, S. Chow, D. Khalaf, V. Gupta, D. D. H. Kim, D. Maze, M. M. Minden, T. Murphy, D. Sanford, A. D. Schimmer, A. C. Schuh, J. Sibai, K. Yee, H. Sibai

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL

    S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2... oleh P. L. Zinzani, J. Mayer, R. Auer, F. Bijou, A. C. de Oliveira, C. R. Flowers, M. Merli, K. Bouabdallah, P. S. Ganly, Y. Song, H. Zhang, R. Johnson, A. M García-Sancho, M. Provencio, M. Trněný, S. Yuen, H. Tilly, E. Kingsley, G. Tuyman, S. E. Assouline, E. Ivanova, P. Kim, J. Huang, R. Delarue, J. Trotman

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: